Our findings suggest that the rare and novel variants identified in two potential key proteins (LILRB1 and PRSS3) are likely to contribute to IBD pathogenesis via several important immune pathways, such as the innate and adaptive immune system pathways and neutrophil degranulation. This evidence concerns the gene PRSS3 and irritable bowel syndrome.